Snapshot

DOI:

State-of-the-Art review on the imaging of atherosclerotic plaques; low-dose prasugrel monotherapy in acute coronary syndrome; supersaturated oxygen therapy in acute anterior myocardial infarction; resting pullback pressure gradient; nicardipine and coronary hyperaemia; anticoagulation for HALT; the potential of factor XI inhibition; news from EAPCI; and more

What is your interest? Plaque pathology? The latest DAPT regimens? Comparing approaches to FFR or PPG? We’ve got all the bases covered in this latest summer edition of our Journal!

Imaging of atherosclerotic plaques

In this state-of-the-art, Hector M. Garcia-Garcia, Fernando Alfonso, and colleagues delve into the world of plaque pathology and how intravascular imaging can be used to identify and characterise the components of plaque and their phenotypes. Their proposition of a new imaging-based nomenclature for high-risk plaque characteristics is preceded by a natural history of plaque and followed by a review of pharmacological trials that have used different imaging methods to study the evolution and morphology of plaque.

Low-dose prasugrel following one-month dual antiplatelet therapy in acute coronary syndromes

In one of the most discussed trials presented at EuroPCR 2025, Youngwoo Jang, Woong Chol Kang, and colleagues evaluate the safety and efficacy of a 1-month prasugrel-based dual antiplatelet regimen followed by reduced-dose monotherapy in acute coronary syndrome patients receiving a drug-coated stent. This strategy reduced the primary endpoint, a 1-year net adverse clinical events endpoint, by 49%, primarily driven by a 77% reduction in bleeding events. This article is accompanied by an editorial by Thomas Cuisset and Guillaume Cayla.

Supersaturated oxygen therapy in patients with acute anterior myocardial infarction

Tobias König, Andreas Schäfer, and colleagues investigate whether supersaturated oxygen (SSO2) therapy impacts microvascular obstruction and final infarct size in first-time, haemodynamically stable, acute anterior myocardial infarction patients. Twenty patients receiving 60 minutes of SSO2 therapy after PCI were compared with the same number who did not receive it. After evaluation, with multimodal imaging strategies, those patients receiving SSO2 therapy demonstrated significantly reduced microvascular obstruction and final infarct size. Gregg W. Stone and Oludamilola Akinmolayemi contribute an editorial on this article.

Resting pullback pressure gradient

In a research correspondence, Koshiro Sakai, Allen Jeremias, and colleagues question whether resting pullback pressure gradients (PPG) could be a practical alternative to hyperaemic PPG for assessing the patterns of coronary artery disease. Their prespecified subanalysis of the PPG Global Registry demonstrated a strong correlation and agreement in pattern classification between resting and hyperaemic PPG.

Factor XI inhibition in ACS

In a viewpoint, Renato D. Lopes and Alexander C. Fanaroff discuss the potential of factor XI/XIa inhibitors, and whether they can truly decouple haemostasis from thrombosis.

Nicardipine and coronary hyperaemia

A second research correspondence compares intracoronary nicardipine with intracoronary papaverine for the measurement of fractional flow reserve and PPG. For authors Michele Mattia Viscusi, Bernard De Bruyne, and colleagues, nicardipine proves to be a promising alternative to papaverine as it induces maximal, steady-state hyperaemia with a significantly longer hyperaemic plateau.

Volume 21 Number 14
Jul 21, 2025
Volume 21 Number 14
View full issue

Suggested by Cory

State-of-the-Art

10.4244/EIJ-D-24-00387 Jul 21, 2025
Advances in coronary imaging of atherosclerotic plaques
Garcia-Garcia H et al
free
Trending articles
317.8

State-of-the-Art Review

10.4244/EIJ-D-21-00695 Nov 19, 2021
Transcatheter treatment for tricuspid valve disease
Praz F et al
free
108.3

Viewpoint

10.4244/EIJ-E-22-00007 May 15, 2022
TAVI at 20: how a crazy idea led to a clinical revolution
Eltchaninoff H et al
free
100.3

State-of-the-Art

10.4244/EIJ-D-24-00066 Apr 21, 2025
Management of complications after valvular interventions
Bansal A et al
free
91.6

Image – Interventional flashlight

10.4244/EIJ-D-22-00344 Aug 5, 2022
First dedicated transcatheter leaflet splitting device: the ShortCut device
Tchétché D et al
free
68.05

State-of-the-Art

10.4244/EIJ-D-24-00992 Sep 15, 2025
Antithrombotic therapy in complex percutaneous coronary intervention
Castiello D et al
free
X

PCR
Impact factor: 9.5
2024 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2025)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2025 Europa Group - All rights reserved